Resources

Filter by:

A bispecific nanobody for the treatment of von Willebrand disease type 1

Peyron I, Casari C, McCluskey G, Licari V, Bocquet E, Auditeau C, Daniel MY, Roullet S, Susen S, Christophe OD, Lenting PJ, & Denis CV
2025 Must-Read Von Willebrand Disease

Clinically relevant outcomes for research in pediatric pulmonary embolism: communication from the ISTH SSC Subcommittee on Pediatric/Neonatal Thrombosis and Hemostasis

Zia A, Whitworth H, Avila L, Klok FA, Alqahtani M, Gopalan D, Griffiths M, Rosovsky RP, Williams S, Babb TG, Rajpurkar M
Clotting & Clotting Disorders

Iron Deficiency and Anemia in Menstruating Adolescents

Raj R, Menon N, & Srivaths L
2025 Must-Read Iron Disorders

HPA-1a antibodies in FNAIT do not distinguish αvβ3 from αIIbβ3, and bind inactive integrins more strongly than active integrins

Oosterhoff JJ, Stam W, van Brummelen SR, Bentlage AEH, de Vos T, de Pereda JM, Porcelijn L, Kapur R, de Haas M, van der Schoot CE, Vidarsson G, & Margadant C
2025 Must-Read Platelets

Venous thromboembolism in obese hormonal contraceptive users: a large national database study

Divyaswathi CS, Rajpurkar M, Srivaths L, Samuelson Bannow B, Rosovsky RP, & Sokkary N
2025 Must-Read LAN Developed

Effect of age on ISTH-BAT scores and low VWF diagnosis in the Zimmerman Program

Atiq F, Christopherson PA, Doherty D, Hulshof AM, Haberichter SL, Flood VH, Lavin M, O’Connell NM, Ryan K, Byrne M, Grabell J, James PD, Lillicrap D, Montgomery RR, Di Paola J, & O’Donnell JS
2025 Must-Read Von Willebrand Disease